Menopause is having a long-overdue moment in mainstream wellness conversations, and cannabis is part of that story. Across surveys conducted in the United States and Canada, a striking share of perimenopausal and postmenopausal women report turning to cannabis for the sleep disruption, mood swings, and persistent anxiety that often define this life stage. For New York consumers exploring premium flower as part of a thoughtful wellness routine, it is worth understanding what the latest research actually suggests, and where it stops short.
Studies indicate cannabis use during midlife is widespread and self-reported as helpful, but high-quality randomized clinical trials remain limited. The honest summary: there is enough evidence to take women's experiences seriously, and not yet enough to offer hard medical claims.
Why Midlife Women Are Paying Attention
Perimenopause, the transition that typically begins in a woman's 40s and can stretch for a decade, brings shifting estrogen levels that ripple through sleep, mood, cognition, body temperature, and joint comfort. Postmenopause, defined as 12 months without a period, often carries its own profile of sleep fragmentation and low-grade anxiety. Conventional treatments help many women, but research suggests a meaningful share feel underserved. One 2025 survey of UK clinicians found that 76% believed treatment options for menopause and related conditions remain too limited.[1] That gap helps explain why cannabis has entered the conversation, especially in regulated markets like New York where licensed flower comes with lab testing and detailed terpene information.
What Recent Surveys Found
A peer-reviewed survey published in the journal Menopause in 2022 examined cannabis use among 258 perimenopausal and postmenopausal women in the United States. Among those using cannabis for menopause-related symptoms, the most commonly targeted complaints were sleep disturbance (about 67% of users) and mood or anxiety (about 46%).[2] A 2023 cross-sectional survey in Alberta, Canada, reached similar conclusions, with most current users reporting cannabis was at least somewhat helpful for symptom relief.[3]
A separate 2024 qualitative study added depth to those numbers. Women described cannabis as one element of a broader self-managed approach, often combined with diet changes, exercise, supplements, and conversations with healthcare providers. Many framed it as a tool for reclaiming control during a confusing transition rather than a cure.[4]
It is worth noting what these surveys are and are not. They capture self-reported experience at scale, which is useful for an under-studied population. They do not establish cause and effect, control for placebo, or replace a randomized clinical trial.
Sleep, Mood, and the Limits of the Evidence
Where survey data converges, the case is most plausible. Studies indicate that the symptoms most consistently linked to cannabis benefit during midlife are sleep disturbance and mood or anxiety. A 2021 systematic review of cannabis use in perimenopausal and postmenopausal women drew the same conclusion, while flagging the small sample sizes and absence of placebo controls in much of the underlying literature.[5]
Hot flashes are a different story. Across multiple surveys, women report that cannabis is less helpful for vasomotor symptoms than for sleep or mood. Researchers have offered a plausible biological explanation: the hypothalamus, which regulates body temperature, is not believed to be strongly modulated by cannabinoids in the way that sleep and mood pathways are.[2] Early findings show cannabis may indirectly help with the sleep disruption that hot flashes cause, even if it does not prevent the hot flash itself.
It is also worth noting that broader 2026 research on cannabis and mental health has produced mixed signals. A systematic review and meta-analysis published in The Lancet Psychiatry in 2026 concluded that high-quality evidence for cannabinoids as treatments for anxiety, PTSD, and depression remains sparse, and called for more rigorous trials.[6] That does not negate self-reported relief during menopause, but it does reinforce why cannabis should be considered alongside, not as a replacement for, qualified medical care.
How Terpenes Fit In
For women specifically interested in sleep and mood support, the terpene profile of a strain is often more informative than the indica or sativa label. A few terpenes show up repeatedly in this conversation. Myrcene, the most common cannabis terpene, is associated with sedating, relaxing effects. Linalool, the same terpene that gives lavender its scent, is associated with calm mood. Caryophyllene is associated with stress relief and interacts with the body's own endocannabinoid system. Pinene, by contrast, is associated with alertness and may be a better daytime fit for someone who wants to take the edge off without feeling foggy. Our guide to the entourage effect goes deeper on how these compounds work together.
Greenline's strains feature detailed terpene and cannabinoid profiles, so consumers can match selection to intent rather than guess from a category label.
What Symptom-Targeted Selection Can Look Like
| Symptom Focus | What Studies Indicate | Common Terpene Targets |
|---|---|---|
| Sleep disturbance | Most consistently reported area of perceived benefit in surveys | Myrcene, Linalool |
| Mood and anxiety | Frequently reported as helpful, though clinical trial evidence is limited | Linalool, Caryophyllene |
| Tension and discomfort | Early findings show cannabinoids may modulate inflammatory pathways, but evidence is mixed | Caryophyllene, Myrcene |
| Hot flashes | Less consistent benefit reported; cannabis may help indirectly via sleep | Mixed; consider lighter hybrids |
| Daytime focus and mood lift | Anecdotal; pinene-rich, lower-THC strains favored | Pinene, Terpinolene |
A Sensible Approach for Newer Consumers
Many women approaching cannabis in midlife are returning after long breaks, or trying premium flower for the first time. A few principles are worth keeping in mind.
Start low and go slow. Modern flower often runs well over 20% THC, far above what older consumers may remember. Begin with a small amount of a moderate-THC strain and wait long enough to feel the full effect before consuming more. Our microdosing research overview covers what the latest data suggests about lower doses.
Match the strain to the moment. An indica-leaning strain rich in linalool and myrcene may suit an evening wind-down. A balanced hybrid is often a steadier daytime choice than a high-THC sativa, which can amplify anxiety for newer consumers.
Talk to a healthcare provider. Cannabis interacts with several medication classes, including sleep aids, antidepressants, and blood thinners. Anyone taking prescription medication should loop in a qualified clinician before adding cannabis to a routine.
Track what works. A simple log of strain, dose, time of day, and effect is one of the most underrated tools for finding what fits. Patterns emerge quickly, and terpene profile often matters more than the indica or sativa label.
Where the Research Goes From Here
Research on cannabis and menopause is accelerating. A Phase 2 clinical trial registered in 2026 is testing hemp-derived cannabinoids against placebo for menopause-related anxiety and mental fatigue, the kind of controlled study the field has been short on.[7] New York's licensed market is also maturing, with more women-led brands and educational programming aimed at midlife consumers.
For now, the most defensible read of the evidence is simple. Survey research suggests cannabis is widely used and widely perceived as helpful for sleep and mood during the menopause transition. Hot flashes appear to be a weaker target. Clinical trial evidence is still catching up. Consumers who get the most out of cannabis in midlife tend to treat it as one tool inside a larger plan, with attention to dose, terpene profile, and conversations with their care team.
Frequently Asked Questions
Can cannabis help with menopause symptoms?
Survey research suggests that many perimenopausal and postmenopausal women use cannabis to help manage sleep disturbance, mood changes, and anxiety associated with the menopause transition. A peer-reviewed survey published in Menopause found that, among women using cannabis for menopause-related symptoms, sleep disturbance and mood/anxiety were the most commonly reported targets. High-quality randomized clinical trials are still limited, so cannabis should be considered alongside, not as a replacement for, guidance from a qualified healthcare provider.
Does cannabis help with hot flashes?
Current evidence on cannabis and hot flashes is limited. In survey data, women reported that cannabis was less helpful for vasomotor symptoms like hot flashes than for sleep or mood. The hypothalamus, the brain region that regulates body temperature, is not believed to be strongly modulated by cannabinoids in the way that sleep and mood pathways are. More clinical research is needed.
What kind of cannabis strain might be best during perimenopause?
Many midlife consumers prioritize sleep and mood support, which often points to indica-leaning or balanced hybrid strains rich in myrcene, linalool, and caryophyllene. For daytime use without heavy sedation, a balanced hybrid with moderate THC is often a more comfortable starting point than a high-THC sativa. Greenline's strains feature detailed terpene and THC information so consumers can choose based on their specific goals.
Is cannabis a substitute for hormone therapy?
No. Cannabis is not a substitute for hormone therapy or other treatments validated for menopause symptoms. Research on cannabis for menopause is still early-stage, and decisions about menopause care should be made with a qualified healthcare provider. Cannabis may serve as one tool within a broader, individualized wellness plan.
How should someone new to cannabis start during perimenopause or menopause?
A common harm-reduction approach is to start low and go slow: choose a strain with moderate THC (under 20%), use a small amount, and wait long enough to feel the full effect before consuming more. Pay attention to terpene profiles, log how different strains feel, and discuss cannabis use with a healthcare provider, especially if you take other medications.
References
- Alternaleaf. Survey of UK NHS doctors on women's health treatment options. Business of Cannabis. 2025. businessofcannabis.com
- Dahlgren MK, El-Abboud C, Lambros AM, et al. A survey of medical cannabis use during perimenopause and postmenopause. Menopause. 2022;29(9):1028-1036. PubMed:35917529
- Sliwinski JR, Johnson AK, Elkins GR, et al. Cannabis use for menopause in women aged 35 and over: a cross-sectional survey on usage patterns and perceptions in Alberta, Canada. Menopause. 2023;30(7):667-674. PMC10314536
- Slawek DE, Syed M, Cunningham CO, et al. Women's perceptions and experiences with cannabis use in menopause: a qualitative study. Menopause. 2024. PubMed:38980742
- Mejia-Gomez J, Phung N, Philippopoulos E, et al. The impact of cannabis use on vasomotor symptoms, mood, insomnia and sexuality in perimenopausal and postmenopausal women: a systematic review. Journal of Obstetrics and Gynaecology Canada. 2021;43(7):901-908. PubMed:33759668
- Black N, Stockings E, Campbell G, et al. The efficacy and safety of cannabinoids for the treatment of mental disorders and substance use disorders: a systematic review and meta-analysis. The Lancet Psychiatry. 2026. thelancet.com
- Phase 2 clinical trial: Hemp-derived cannabinoids for menopause-related anxiety and mental fatigue. Trial information via Power. 2026. withpower.com
Find a strain that matches your evening, your morning, or somewhere in between.
Explore Greenline Strains